Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 40

1.

Addressing quality of life and end-of-life decisions with patients.

Hercz G, Novak M.

CANNT J. 2014 Jan-Mar;24(1):34. No abstract available.

PMID:
24783771
[PubMed - indexed for MEDLINE]
2.

The challenges presented by the non-compliant patient.

Hercz G, Novak M.

CANNT J. 2013 Oct-Dec;23(4):30. No abstract available.

PMID:
24660522
[PubMed - indexed for MEDLINE]
3.

Understanding the hemodialysis patient with dementia.

Hercz G.

CANNT J. 2013 Jul-Sep;23(3):38-9. No abstract available.

PMID:
24344522
[PubMed - indexed for MEDLINE]
4.

The 5th modality: psychonephrology.

Novak M, Hercz G.

CANNT J. 2013 Apr-Jun;23(2):59-60. No abstract available.

PMID:
24069701
[PubMed - indexed for MEDLINE]
5.

Development and utility of a multi-dimensional grid to assess individual mineral metabolism control in hemodialysis patients: A potential aid for therapeutic decision making?

Morton AR, Murphy S, Hirsch D, Leblanc M, Barré P, Lok C, Hercz G, Hodsman A, Reslerova M, Levin A.

Hemodial Int. 2010 Apr;14(2):200-10. doi: 10.1111/j.1542-4758.2009.00426.x. Epub 2010 Mar 12.

PMID:
20337745
[PubMed - indexed for MEDLINE]
6.

The effects of discontinuing cinacalcet at the time of kidney transplantation.

Jadoul M, Baños A, Zani VJ, Hercz G.

NDT Plus. 2010 Feb;3(1):37-41. Epub 2009 Dec 4.

PMID:
20090879
[PubMed]
Free PMC Article
7.

The natural history of the non-nephrotic membranous nephropathy patient.

Hladunewich MA, Troyanov S, Calafati J, Cattran DC; Metropolitan Toronto Glomerulonephritis Registry.

Clin J Am Soc Nephrol. 2009 Sep;4(9):1417-22. doi: 10.2215/CJN.01330209. Epub 2009 Aug 6.

PMID:
19661220
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wüthrich RP, Gottlow M, Johnsson E, Zannad F; AURORA Study Group.

N Engl J Med. 2009 Apr 2;360(14):1395-407. doi: 10.1056/NEJMoa0810177. Epub 2009 Mar 30. Erratum in: N Engl J Med. 2010 Apr 15;362(15):1450.

PMID:
19332456
[PubMed - indexed for MEDLINE]
Free Article
9.

Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden.

Hutchison AJ, Laville M; SPD405-313 Lanthanum Study Group.

Nephrol Dial Transplant. 2008 Nov;23(11):3677-84. doi: 10.1093/ndt/gfn310. Epub 2008 Jun 24.

PMID:
18577536
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy.

Bakris G, Burgess E, Weir M, Davidai G, Koval S; AMADEO Study Investigators.

Kidney Int. 2008 Aug;74(3):364-9. doi: 10.1038/ki.2008.204. Epub 2008 May 21.

PMID:
18496508
[PubMed - indexed for MEDLINE]
11.

The impact of sex in primary glomerulonephritis.

Cattran DC, Reich HN, Beanlands HJ, Miller JA, Scholey JW, Troyanov S; Genes, Gender and Glomerulonephritis Group.

Nephrol Dial Transplant. 2008 Jul;23(7):2247-53. doi: 10.1093/ndt/gfm919. Epub 2008 Jan 8.

PMID:
18182409
[PubMed - indexed for MEDLINE]
Free Article
12.

Response to 'The low-calcium concentration of dialysate induced a marked increase of serum parathyroid hormone level in a continuous ambulatory peritoneal dialysis patient'.

Haris A, Sherrard DJ, Hercz G.

Kidney Int. 2007 Mar;71(6):594-5. No abstract available.

PMID:
17344898
[PubMed - indexed for MEDLINE]
13.

Reversal of adynamic bone disease by lowering of dialysate calcium.

Haris A, Sherrard DJ, Hercz G.

Kidney Int. 2006 Sep;70(5):931-7. Epub 2006 Jul 12.

PMID:
16837920
[PubMed - indexed for MEDLINE]
14.

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.

Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drüeke TB, Goodman WG.

N Engl J Med. 2004 Apr 8;350(15):1516-25.

PMID:
15071126
[PubMed - indexed for MEDLINE]
Free Article
15.

Association between fluoride, magnesium, aluminum and bone quality in renal osteodystrophy.

Ng AH, Hercz G, Kandel R, Grynpas MD.

Bone. 2004 Jan;34(1):216-24.

PMID:
14751580
[PubMed - indexed for MEDLINE]
16.

Regulation of bone remodeling: impact of novel therapies.

Hercz G.

Semin Dial. 2001 Jan-Feb;14(1):55-60. Review.

PMID:
11208041
[PubMed - indexed for MEDLINE]
17.

Screening plasma aluminum levels in relation to aluminum bone disease among asymptomatic dialysis patients.

Kausz AT, Antonsen JE, Hercz G, Pei Y, Weiss NS, Emerson S, Sherrard DJ.

Am J Kidney Dis. 1999 Oct;34(4):688-93.

PMID:
10516350
[PubMed - indexed for MEDLINE]
18.

Relative hypoparathyroidism and adynamic bone disease.

Mucsi I, Hercz G.

Am J Med Sci. 1999 Jun;317(6):405-9. Review.

PMID:
10372841
[PubMed - indexed for MEDLINE]
19.

Control of serum phosphate in patients with renal failure--new approaches.

Mucsi I, Hercz G.

Nephrol Dial Transplant. 1998 Oct;13(10):2457-60. Review. No abstract available.

PMID:
9794538
[PubMed - indexed for MEDLINE]
Free Article
20.

Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis.

Mucsi I, Hercz G, Uldall R, Ouwendyk M, Francoeur R, Pierratos A.

Kidney Int. 1998 May;53(5):1399-404.

PMID:
9573558
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk